Literature DB >> 9304697

Cytokines which signal through the LIF receptor and their actions in the nervous system.

M Murphy1, R Dutton, S Koblar, S Cheema, P Bartlett.   

Abstract

A number of different cytokines, each initially characterized on the basis of very different biological activities, all have very similar signalling pathways and share a similar tertiary structure. These cytokines include leukaemia inhibitory factor, ciliary neuronotrophic factor, oncostatin M, growth-promoting activity and cardiotrophin 1. They all have been found to regulate a number of properties of cells of the developing and mature nervous system in vitro and thus are neuroregulatory cytokines. The actions of these cytokines include regulation of neurotransmitter phenotype, differentiation of neuronal precursor cells both in the peripheral nervous system and in the spinal cord, survival of differentiated neurons, and regulation of development of both astrocytes and oligodendrocytes. In addition, studies in animal models show that these factors can rescue sensory and motor neurons from axotomy-induced cell death, which suggests that they can act as trauma factors for injured neurons. Analysis of the expression patterns of the different neuroregulatory cytokines and their receptors reveals that the receptors are expressed throughout nervous system development and following trauma, whereas the cytokines show temporal and spatial specific expression patterns. This is consistent with the idea that specific cytokines have specific roles in neural development and repair, but that their signalling pathways are shared. The phenotypes of the receptor knockouts show clear deficits in nervous system development, indicating a crucial role for LIF receptor signalling. Knockouts of individual cytokines are less dramatic, but LIF and CNTF knockouts do reveal deficits in maintenance of motor neurons or following trauma. Thus, whereas LIF and CNTF have clear roles in maintenance and following trauma, it is unclear which of the cytokines is involved in nervous system development. In clinical terms, these findings add further support to the use of these cytokines in nervous system trauma and disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9304697     DOI: 10.1016/s0301-0082(97)00020-8

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  36 in total

1.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

Review 2.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 3.  Challenges in the study of neuronal differentiation: a view from the embryonic eye.

Authors:  Ruben Adler
Journal:  Dev Dyn       Date:  2005-11       Impact factor: 3.780

Review 4.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

5.  Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury.

Authors:  A Blesch; H S Uy; R J Grill; J G Cheng; P H Patterson; M H Tuszynski
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

Review 6.  CNTF and retina.

Authors:  Rong Wen; Weng Tao; Yiwen Li; Paul A Sieving
Journal:  Prog Retin Eye Res       Date:  2011-12-10       Impact factor: 21.198

Review 7.  Astrogliosis in CNS pathologies: is there a role for microglia?

Authors:  Dan Zhang; Xiaoming Hu; Li Qian; James P O'Callaghan; Jau-Shyong Hong
Journal:  Mol Neurobiol       Date:  2010-02-12       Impact factor: 5.590

Review 8.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing.

Authors:  Darren H Freed; Michael C Moon; Anna M Borowiec; Stephen C Jones; Peter Zahradka; Ian M C Dixon
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

Review 10.  Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Authors:  Y Wang; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.